Pharmacokinetics of Ciprofloxacin in Broiler Chickens After Single Intravenous and Intraingluvial Administration

Author:

Ivanova Sofiya1,Dimitrova Dimitrichka2,Petrichev Metodi1

Affiliation:

1. Non-infectious Diseases Unit, National Diagnostic and Research Veterinary Medical Institute , Sofia , Bulgaria

2. Department of Internal Non-infectious Diseases, Pathology and Pharmacology , Faculty of Veterinary Medicine of the University of Forestry , Sofia , Bulgaria

Abstract

Abstract The trial was performed on 10 clinically healthy Ross hybrid chickens, 5 from each gender, weighing 2.75-2.84 kg. The tested quinolone was applied at the same dose for both routes of application - 10 mg/kg of body weight. Ciprofloxacin hydrochloridum 5% solution for i.v. and 1% solution for intraingluvial treatment were prepared. In a crossover study design, ciprofloxacin hydrochloridum was administered as 5 % solution for i.v. bolus injection to broiler chickens and after 14 days as 1 % solution for intraingluvial administration into a crop to the same birds. Serum ciprofloxacin concentrations were assayed by HPLC with UV detection at a wavelength of 279 nm. After intravenous injection the following pharmacokinetic parameters were determined: t1/2β = 9.07 h; t1/2α= 0.36 h; MRT = 10.20 h and MRT = 10.75 h; AUC0→∞ = 19.560 μg.h/mL and AUC0→∞ = 19.843 μg.h/mL. After intraingluvial application parameters determined by the two pharmacokinetic models were as: t1/2α= 0.86 h; t1/2β = 7,20 h and t1/2β = 7.89 h; MRT = 12.67 h and MRT = 12.93 h; AUC0→∞ = 11.340 μg.h/mL and AUC0→24 h = 11.973 μg.h/mL; Cmax = 2.841 μg/mL and Cmax = 2.638 μg/mL; Tmax = 0.48 h and Tmax = 0.39 h; t1/2abs. = 0.146 h; MAT = 2.47 h and MAT = 2.18 h; F = 57.91% and F = 63.89%. These results suggested that a dose of 10 mg/kg of body weight provides maximum plasma concentration ater intraingluvial administration and is effective in the control of many infectious diseases of poultry.

Publisher

Walter de Gruyter GmbH

Subject

General Veterinary

Reference20 articles.

1. 1. Hannan, P.C.T., O′Hanlon, P.J., Rogers, N.H. (1989). In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Research in Veterinary Science 46, 202−211. PMid:2704885

2. 2. Prescott, J., Yielding, K.H. (1990). In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research 54, 195-197.

3. 3. Neer, T.M. (1988). Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. Journal of American Veterinary Medical Association 193, 577-580.

4. 4. Vancustem, P.M., Babish, J.G., Schwark, W.S. (1990). The fluoroquinolone antimicrobials, clinical use in domestic animals and toxicity. Cornell Veterinarian 80, 173-186.

5. 5. Gellert M. (1981). DNA topoisomerases. Annual Reviews of Biochemistry 50, 879-910. https://doi.org/10.1146/annurev.bi.50.070181.004311 PMid:6267993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3